These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36565543)

  • 1. Corrigendum to "Cognitive trajectories during and after electroconvulsive therapy in patients with MDE: Taking different perspectives" [J. Psychiatr. Res. 152 (2022) 132-140].
    Hebbrecht K; Dejaeger M; Giltay EJ; Birkenhäger T; Sabbe B; Verwijk E; Obbels J; Schrijvers D; Van Diermen L
    J Psychiatr Res; 2023 Feb; 158():41. PubMed ID: 36565543
    [No Abstract]   [Full Text] [Related]  

  • 2. Cognitive trajectories during and after electroconvulsive therapy in patients with MDE: Taking different perspectives.
    Hebbrecht K; Dejaeger M; Giltay EJ; Birkenhäger T; Sabbe B; Verwijk E; Obbels J; Schrijvers D; Van Diermen L
    J Psychiatr Res; 2022 Dec; 156():132-140. PubMed ID: 36252342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Impaired socio-affective, but intact socio-cognitive skills in patients with treatment-resistant, recurrent depression" [J. Psychiatr. Res. 153 (2022) 206-212 / https://doi.org/10.1016/j.jpsychires.2022.07.025].
    Kilian HM; Schiller B; Schläpfer TE; Heinrichs M
    J Psychiatr Res; 2024 Apr; 172():198-199. PubMed ID: 38401364
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Neuropsychiatric symptoms influence differently cognitive decline in older women and men" [J. Psychiatr. Res. 154 (2022) 1-9].
    Ronat L; Monchi O; Hanganu A;
    J Psychiatr Res; 2023 May; 161():476. PubMed ID: 37062108
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Altered levels of fecal short-chain fatty acids are associated with subclinical inflammation and worse cognitive performance in patients with schizophrenia" [J. Psychiatr. Res. 165 (2023) 298-304].
    Kowalski K; Szponar B; Bochen P; Żebrowska-Różańska P; Łaczmański Ł; Samochowiec J; Misiak B
    J Psychiatr Res; 2024 Jan; 169():191. PubMed ID: 38042057
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials" [J. Psychiatr. Res. 155 (2022) 371-379].
    Qin M; Wu J; Zhou Q; Liang Z; Su Y
    J Psychiatr Res; 2022 Dec; 156():44. PubMed ID: 36242942
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Anticoagulation therapy and outcomes in patients with atrial fibrillation and serious mental illness: A systematic review and meta-analysis" [J. Psychiatr. Res. 156 (2022) 737-753].
    Farran D; Feely O; Ashworth M; Gaughran F
    J Psychiatr Res; 2023 Nov; 167():149. PubMed ID: 36581540
    [No Abstract]   [Full Text] [Related]  

  • 8. Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: A matched retrospective cohort study.
    Kaster TS; Goldbloom DS; Daskalakis ZJ; Mulsant BH; Blumberger DM
    Brain Stimul; 2018; 11(1):204-212. PubMed ID: 29111076
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to"Ketamine metabolite pilot study in a suicidal depression trial" [J Psychiatr Res 117 (2019) 129-134. doi: 10.1016/j.jpsychires.2019.08.005. Epub 2019 Aug 9].
    Grunebaum MF; Galfalvy HC; Choo TH; Parris MS; Burke AK; Suckow RF; Cooper TB; Mann JJ
    J Psychiatr Res; 2019 Dec; 119():32. PubMed ID: 31550622
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Can machine learning be useful as a screening tool for depression in primary care?" [J. Psychiatr. Res. 2021 Jan; 132:1-6. doi: 10.1016/j.jpsychires.2020.09.025].
    Marques de Souza Filho E; Veiga Rey HC; Frajtag RM; Arrowsmith Cook DM; Dalbonio de Carvalho LN; Pinho Ribeiro AL; Amaral J
    J Psychiatr Res; 2022 Apr; 148():61-62. PubMed ID: 35121269
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Antidepressant and neurocognitive effects of serial ketamine administration versus ECT in depressed patients" [J. Psychiatr. Res. 123 (2020) 1-8].
    Basso L; Bönke L; Aust S; Gärtner M; Heuser-Collier I; Otte C; Wingenfeld K; Bajbouj M; Grimm S
    J Psychiatr Res; 2020 May; 124():143. PubMed ID: 32155477
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "The dimensional structure of psychopathology in 22q11.2 Deletion Syndrome" [J. Psychiatr. Res. 92 (2017) 124-131].
    Niarchou M; Moore TM; Tang SX; Calkins ME; McDonald-McGuinn DM; Zackai EH; Emanuel BS; Gur RC; Gur RE
    J Psychiatr Res; 2019 Nov; 118():8. PubMed ID: 31445317
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Learning from gain and loss: Links to suicide risk" [J. Psychiatr. Res. 147 (2022) 126-134].
    Dixon-Gordon KL; Waite EE; Ammerman BA; Haliczer LA; Boudreaux ED; Rathlev N; Cohen AL
    J Psychiatr Res; 2022 May; 149():265. PubMed ID: 35305379
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Prediction of suicide among 372,813 individuals under medical check-up" [J. Psychiatr. Res. 131 (2020) 9-14].
    Cho SE; Geem ZW; Na KS
    J Psychiatr Res; 2021 Mar; 135():152. PubMed ID: 33486163
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Sons and parental cognition in mid-life and older adulthood" [J. Psychiatr. Res. 156 (2022) 284-290].
    Wolfova K; Wu D; Weiss J; Cermakova P; Kohler HP; Skirbekk VF; Stern Y; Gemmill A; Tom SE
    J Psychiatr Res; 2023 Apr; 160():8. PubMed ID: 36764196
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "What about mental health after one year of COVID-19 pandemic? A comparison with the initial peak" [J. Psychiatr. Res. 153 (2022) 104-108].
    García-Fernández L; Romero-Ferreiro V; Rodríguez V; Alvarez-Mon MA; Lahera G; Rodriguez-Jimenez R
    J Psychiatr Res; 2022 Oct; 154():10. PubMed ID: 35870441
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Acupuncture treatment modulates the corticostriatal reward circuitry in major depressive disorder" [J. Psychiatr. Res. 84 (2017) 18-26].
    Wang Z; Wang X; Liu J; Chen J; Liu X; Nie G; Jorgenson K; Sohn KC; Huang R; Liu M; Liu B; Kong J
    J Psychiatr Res; 2017 Apr; 87():105. PubMed ID: 28126211
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Social context and loneliness in an epidemiological youth sample using the experience sampling method" [J. Psychiatr. Res. 156 (2022) 429-436].
    Chor-Yin Tang W; Sau-Man Wong C; Wong TY; Lai-Ming Hui C; Ming-Yin Wong S; Suen YN; Kit-Wa Chan S; Chang WC; Ho-Ming Lee E; Sai-Yu Lui S; Chan KT; Tak-Hing Wong M; Myin-Germeys I; Yu-Hai Chen E
    J Psychiatr Res; 2023 May; 161():1. PubMed ID: 37129983
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Brain penetration of ketamine: Intranasal delivery VS parenteral routes of administration" [J. Psychiatr. Res. 112 (2019) 7-11].
    Naidoo V; Mdanda S; Ntshangase S; Naicker T; Kruger HG; Govender T; Naidoo P; Baijnath S
    J Psychiatr Res; 2023 Sep; 165():254. PubMed ID: 37536188
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Stress, resilience, and coping strategies in a sample of community-dwelling older adults during COVID-19" [J. Psychiatr. Res. 138 (2021) 176-185].
    Vannini P; Gagliardi GP; Kuppe M; Dossett ML; Donovan NJ; Gatchel JR; Quiroz YT; Premnath PY; Amariglio R; Sperling RA; Marshall GA
    J Psychiatr Res; 2021 Oct; 142():167-170. PubMed ID: 34359011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.